| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042702615 |
| P356 | DOI | 10.2165/00003495-199244030-00007 |
| P698 | PubMed publication ID | 28634917 |
| P50 | author | Rex N. Brogden | Q62563651 |
| P2093 | author name string | D. McTavish | |
| Donna McTavish | |||
| P2507 | corrigendum / erratum | Erratum to: Budesonide. | Q53915819 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 375-407 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis | |
| P478 | volume | 44 |
| Q44388512 | A novel method for assessing dissolution of aerosol inhaler products |
| Q44042784 | A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis |
| Q30582623 | A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis |
| Q72524739 | Adverse effects of inhaled corticosteroids |
| Q43235590 | Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis. |
| Q74493310 | Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma |
| Q31954896 | Budesonide in inflammatory bowel disease: a meta-analysis |
| Q37678433 | Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy |
| Q77800095 | Colon-specific delivery of budesonide with azopolymer-coated pellets: therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats |
| Q40552121 | Comparison of clinical effects of beclomethasone dipropionate & budesonide in treatment of children with mild persistent asthma: A double-blind, randomized, controlled study. |
| Q35627751 | Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials |
| Q43903086 | Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial |
| Q49079002 | Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. |
| Q27023118 | Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| Q42477207 | Cytokine profile of human bronchoalveolar macrophages and bronchial epithelial cells in response to inhalation particles of the cyclosporine derivative IMM 125. |
| Q77486023 | Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region |
| Q64907871 | Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. |
| Q40987121 | Early COPD Exacerbation Treatment with Combination of ICS and LABA for Patients Presenting with Mild-to-Moderate Worsening of Dyspnea |
| Q31795152 | Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn's disease |
| Q44051945 | Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. |
| Q42083069 | Effects of local and systemic budesonide on allergen-induced airway reactions in the pig. |
| Q44478297 | Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma |
| Q41728966 | Efficacy and safety of inhaled corticosteroids. New developments |
| Q42672485 | Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma |
| Q36792765 | Evidence of the in vivo esterification of budesonide in human airways |
| Q45295744 | Immunosuppressive effect of budesonide on human lamina propria lymphocytes |
| Q57656631 | Impact of inhaled corticosteroids on asthma hospitalization in Sweden |
| Q33715425 | Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol |
| Q39443746 | Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine |
| Q39313999 | Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion |
| Q43908983 | Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids |
| Q43655195 | Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids |
| Q43655193 | Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma |
| Q30311870 | Oral Budesonide in the Management of Crohn's Disease |
| Q73026352 | Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial |
| Q77917889 | Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group |
| Q35841000 | Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group |
| Q74217100 | Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety |
| Q41752111 | Pharmacokinetics and pharmacodynamics of inhaled corticosteroids |
| Q46272618 | Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD. |
| Q42674809 | Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology |
| Q34649548 | Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST). |
| Q41669268 | Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma |
| Q38501680 | Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment |
| Q46859854 | Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease |
| Q49103338 | Short courses of high-dose inhaled budesonide and serum IgG subclass levels in healthy volunteers |
| Q57072321 | The Childhood Asthma Management Program (CAMP) |
| Q39386403 | The effect of budesonide on the cytokine pattern in patients with perennial allergic rhinitis |
| Q37980189 | The role of nebulized therapy in the management of COPD: evidence and recommendations. |
| Q52564986 | Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study. |
| Q53915819 | Erratum to: Budesonide. | main subject | P921 |
Search more.